Saturday, September 28, 2024
HomeNews

News

Armata Pharmaceuticals Announces First Patient Dosed in Phase 1b/2a ‘Disarm’ Study of AP-SA02 in Adults With Bacteremia Due to Staphylococcus Aureus

Armata Pharmaceuticals, Inc., a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, announced that the first patient has been...

KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses

KaliVir Immunotherapeutics, Inc. announced a collaboration and global exclusive licensing agreement with Roche for the discovery, development and commercialization of novel oncolytic vaccinia viruses...

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

Axon Therapies, a private company focused on addressing a root cause of heart failure, announced positive early results from a roll-in cohort for their...

Arcellx Appoints Michelle Gilson as Chief Financial Officer

Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced...

SOFIA Watches a Binary Star System’s Eclipse

With its observations of a special pair of stars at a special moment in their lives, the Stratospheric Observatory for Infrared Astronomy (SOFIA) is...
0FansLike
0FollowersFollow
spot_img

Hot Topics